Literature DB >> 2363083

Boomslang bite--diagnosis and management. A report of 2 cases.

J M Aitchison1.   

Abstract

Bites by boomslang are uncommon and usually occur in adult snake handlers who are aware of the potentially fatal consequences, i.e. disseminated intravascular coagulation with delayed onset of spontaneous haemorrhage. Accidental bites in children are rare. Aids to diagnosis include the description of the bite, identification of the snake, and the recognition of an abnormal bleeding tendency before the onset of spontaneous haemorrhage. Specific boomslang antivenin arrests established bleeding but may not be immediately available, in which case the administration of heparin should be considered. Thrombo-elastography is a useful aid to diagnosis and management.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2363083

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  Southern copperhead venom enhances tissue-type plasminogen activator induced fibrinolysis but does not directly lyse human plasma thrombi.

Authors:  Vance G Nielsen
Journal:  J Thromb Thrombolysis       Date:  2016-07       Impact factor: 2.300

2.  Current treatment for venom-induced consumption coagulopathy resulting from snakebite.

Authors:  Kalana Maduwage; Geoffrey K Isbister
Journal:  PLoS Negl Trop Dis       Date:  2014-10-23

3.  What killed Karl Patterson Schmidt? Combined venom gland transcriptomic, venomic and antivenomic analysis of the South African green tree snake (the boomslang), Dispholidus typus.

Authors:  Davinia Pla; Libia Sanz; Gareth Whiteley; Simon C Wagstaff; Robert A Harrison; Nicholas R Casewell; Juan J Calvete
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-01-24       Impact factor: 3.770

Review 4.  Bioactive Molecules Derived from Snake Venoms with Therapeutic Potential for the Treatment of Thrombo-Cardiovascular Disorders Associated with COVID-19.

Authors:  Fatah Chérifi; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2021-09-09       Impact factor: 2.371

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.